Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study.

Gastric cancer (GC) is frequently diagnosed and treated in advanced tumour stages with poor prognosis. Recent studies have identified isoform 2 of the tight junction protein claudin-18 (CLDN18.2) as a promising target in GC therapy. In this study, we aimed to outline the expression of CLDN18.2 and i...

Full description

Bibliographic Details

Published in:	Virchows Archiv: European Journal of Pathology Vol. 475; no. 5; pp. 563 - 572
Main Authors:	Dottermusch, Matthias, Krüger, Sandra, Behrens, Hans-Michael, Halske, Christine, Röcken, Christoph
Format:	pictorial research tables/charts Journal Article
Published:	Springer Nature Nov2019
Online Access:	View this record in EBSCOhost